ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
2.430
-0.010 (-0.41%)
At close: Jul 1, 2025, 4:00 PM
2.429
-0.001 (-0.05%)
After-hours: Jul 1, 2025, 7:38 PM EDT
ReShape Lifesciences Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$398,611
Profits / Employee
-$192,389
Market Cap
5.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RSLS News
- 18 hours ago - ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - GlobeNewsWire
- 4 days ago - ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - GlobeNewsWire
- 5 days ago - ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys - GlobeNewsWire
- 6 days ago - ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology - GlobeNewsWire
- 19 days ago - ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets - GlobeNewsWire
- 22 days ago - ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering - GlobeNewsWire
- 4 weeks ago - ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update - GlobeNewsWire